GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
O

Onyx Healthcare 6569.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

81.20

-0.49%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 1.31bn

FY2016FY2025

Net income

TWD 112.1m

FY2016FY2025

Free cash flow

TWD 147.5m

FY2016FY2025

Shareholders' equity

TWD 1.57bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 1.31bnTWD 1.24bnTWD 1.49bnTWD 1.60bnTWD 1.20bnTWD 1.35bnTWD 1.48bnTWD 1.42bnTWD 1.30bnTWD 1.13bn
Gross profitTWD 434.0mTWD 456.3mTWD 556.1mTWD 472.3mTWD 363.7mTWD 464.0mTWD 542.6mTWD 464.6mTWD 434.9mTWD 490.6m
Research and developmentTWD 112.5mTWD 118.3mTWD 79.4mTWD 86.7mTWD 79.4mTWD 68.6mTWD 69.0mTWD 66.2mTWD 68.8mTWD 62.7m
Operating incomeTWD 50.3mTWD 90.5mTWD 308.4mTWD 244.2mTWD 143.6mTWD 205.6mTWD 291.2mTWD 181.7mTWD 160.3mTWD 210.4m
Net incomeTWD 112.1mTWD 180.9mTWD 255.3mTWD 203.0mTWD 127.6mTWD 167.1mTWD 239.4mTWD 194.9mTWD 115.9mTWD 164.0m
Diluted earnings per share2.874.666.606.103.704.717.806.293.756.02

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 2.15bnTWD 2.11bnTWD 2.05bnTWD 1.97bnTWD 1.70bnTWD 1.39bnTWD 1.38bnTWD 1.21bnTWD 1.13bnTWD 1.19bn
Cash and short-term investments——TWD 409.8mTWD 336.1mTWD 193.0mTWD 397.9m—TWD 705.4mTWD 653.3mTWD 782.0m
Total liabilitiesTWD 583.6mTWD 553.4mTWD 527.7mTWD 566.0mTWD 667.2mTWD 340.4mTWD 358.9mTWD 297.2mTWD 257.7mTWD 302.9m
DebtTWD 113.1mTWD 251.0mTWD 206.7mTWD 191.9mTWD 315.6mTWD 9.4mTWD 19.9m———
Shareholders' equityTWD 1.57bnTWD 1.54bnTWD 1.51bnTWD 1.39bnTWD 1.03bnTWD 1.04bnTWD 1.01bnTWD 908.0mTWD 870.3mTWD 886.0m
Shares outstanding39m39m39m33m34m35m31m31m31m27m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsTWD 161.8mTWD 124.5mTWD 350.5mTWD 161.8mTWD 17.1mTWD 191.1mTWD 376.5m——TWD 204.3m
Capital spending−TWD 14.3m−TWD 7.1m−TWD 68.0m−TWD 15.1m−TWD 295.9m−TWD 16.8m−TWD 8.8m——−TWD 10.8m
Free cash flowTWD 147.5mTWD 117.4mTWD 282.5mTWD 146.7m−TWD 278.8mTWD 174.3mTWD 367.6m——TWD 193.5m
Dividends paid−TWD 154.5m−TWD 167.6m−TWD 166.3m−TWD 133.0m−TWD 151.3m−TWD 132.0m−TWD 130.0m——−TWD 86.1m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 429.2mTWD 377.4mTWD 315.7mTWD 330.1mTWD 357.5mTWD 309.9mTWD 382.6mTWD 284.0m
Gross profitTWD 124.0mTWD 136.3mTWD 117.2mTWD 99.7mTWD 124.7mTWD 92.5mTWD 148.3mTWD 88.9m
Operating income———−TWD 1.1mTWD 32.9mTWD 6.9mTWD 78.1m−TWD 2.6m
Net incomeTWD 62.8mTWD 40.3mTWD 46.5mTWD 34.1mTWD 24.2mTWD 7.4mTWD 64.8mTWD 26.8m
Diluted earnings per share1.611.031.190.870.620.191.670.69
Cash from operations−TWD 45.0m−TWD 80.0mTWD 28.0m—TWD 24.0mTWD 42.0mTWD 61.0m−TWD 7.0m
Capital spending−TWD 6.0m−TWD 5.0m−TWD 1.0m—−TWD 1.0m−TWD 5.0m−TWD 2.0m−TWD 2.0m
Free cash flow−TWD 51.0m−TWD 85.0mTWD 27.0m—TWD 23.0mTWD 37.0mTWD 59.0m−TWD 9.0m
Total assetsTWD 2.36bnTWD 2.28bnTWD 2.15bn—TWD 2.17bnTWD 2.11bnTWD 2.11bnTWD 2.09bn
DebtTWD 107.6mTWD 110.4mTWD 113.1m—TWD 118.6mTWD 121.3mTWD 123.9mTWD 126.6m
Shareholders' equityTWD 1.55bnTWD 1.60bnTWD 1.57bn—TWD 1.49bnTWD 1.60bnTWD 1.54bnTWD 1.48bn

Financial ratios

Data as of 20 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin33.0%36.8%37.3%29.5%30.3%34.4%
Operating margin9.6%17.0%20.7%15.3%12.0%15.3%
Net margin8.5%14.6%17.1%12.7%10.6%12.4%
Return on equity7.1%11.7%16.9%14.6%12.4%16.0%
Return on assets5.2%8.6%12.5%10.3%7.5%12.0%
Free cash flow yield—3.8%12.1%5.9%——
Revenue growth5.8%-16.9%-6.7%33.2%-10.8%-9.1%
Earnings growth-38.0%-29.1%25.8%59.1%-23.7%-30.2%
Current ratio2.17x2.43x2.85x2.94x1.62x2.73x
Debt to equity0.07x0.08x0.12x0.12x0.27x0.00x
Equity ratio72.9%73.3%73.8%70.8%60.3%74.9%
Interest coverage27.06x48.35x83.70x68.67x54.56x432.02x
R&D as a share of sales8.6%9.5%5.3%5.4%6.6%5.1%
Buybacks as a share of market value—-0.4%-16.3%———

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-6.4%-0.5%3.4%
Operating income-40.9%-24.5%-9.9%
Net income-17.9%-7.7%-0.6%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin34.9%34.0%33.5%34.7%
Operating margin5.5%12.3%12.7%14.0%
Net margin11.5%13.3%12.8%13.0%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings38.132.522.713.924.221.812.611.724.118.4
Price to sales3.34.73.91.82.62.72.01.62.12.7

Dividends and splits

Per share, in the currency the company pays

Paid for 4 years. Last went ex-dividend on 3 Jul 2025.

FY2025FY2024FY2023FY2022
Paid in the year3.9614.3454.3453.479
  • 1149.9016-for-1000 split · 1 Aug 2024
  • 1100-for-1000 split · 24 Aug 2021
  • 1250-for-1000 split · 5 Aug 2020
  • 1100-for-1000 split · 22 Aug 2019
  • 1100-for-1000 split · 27 Jun 2019
  • 1100-for-1000 split · 7 Aug 2017

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.